sec filing
PP
NASDAQ · PPCB
Propanc Biopharma, Inc. Common Stock
Healthcare · Biotechnology
$0.82
Down-$0.19 (-22.56%)
Updated Sep 16, 2026, 10:13 PM
SID Score
4.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 9.77M
- P/E ratio
- -0.15
- Dividend yield
- 0.00%
- 52-week range
- $0.09 – $6.79
- Volume
- 174.11K
- Avg. volume
- 330.85K
Price performance
PPCB price history
1M range · 20 trading sessions · Daily adjusted prices
PPCB closed at $0.82 after 20 trading sessions, down 29.31% for the selected period.
- Last close
- $0.82
- Period change
- -29.31%
- Period low
- $0.82
- Period high
- $2.23
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $0.86 | $0.8803 | $0.813 | $0.82 | 174.11K |
| Sep 14, 2026 | $0.90 | $0.9106 | $0.8283 | $0.85 | 282.88K |
| Sep 11, 2026 | $0.9222 | $0.9349 | $0.8744 | $0.921 | 233.02K |
| Sep 10, 2026 | $0.9734 | $0.9762 | $0.936 | $0.9428 | 129K |
| Sep 9, 2026 | $1.01 | $1.03 | $0.915 | $0.99 | 304.91K |
| Sep 8, 2026 | $1.02 | $1.0399 | $0.9914 | $1.03 | 176.67K |
| Sep 4, 2026 | $1.05 | $1.05 | $0.9715 | $1.01 | 194.4K |
| Sep 3, 2026 | $1.03 | $1.0351 | $0.9697 | $1.02 | 353.67K |
| Sep 2, 2026 | $1.10 | $1.16 | $1.00 | $1.03 | 529.87K |
| Sep 1, 2026 | $1.27 | $1.275 | $1.11 | $1.13 | 623.22K |
| Aug 31, 2026 | $1.29 | $1.48 | $1.25 | $1.35 | 805.07K |
| Aug 28, 2026 | $1.93 | $1.94 | $1.31 | $1.35 | 4.06M |
| Aug 27, 2026 | $3.51 | $4.13 | $1.98 | $2.23 | 97.32M |
| Aug 26, 2026 | $1.119 | $1.12 | $1.07 | $1.07 | 9.77K |
| Aug 25, 2026 | $1.14 | $1.16 | $1.0801 | $1.13 | 15.25K |
| Aug 24, 2026 | $1.10 | $1.19 | $1.08 | $1.155 | 23.02K |
| Aug 21, 2026 | $1.12 | $1.12 | $1.05 | $1.08 | 25.22K |
| Aug 20, 2026 | $1.13 | $1.18 | $1.10 | $1.10 | 20.83K |
| Aug 19, 2026 | $1.185 | $1.185 | $1.10 | $1.14 | 36.89K |
| Aug 18, 2026 | $1.12 | $1.1938 | $1.10 | $1.16 | 33.09K |
Latest PPCB news
The latest Smart Investors Daily articles mentioning PPCB.
Stock researchResearch & News · SEC Filings
Loading stock research…